A detailed history of Aqr Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 546,208 shares of PCRX stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
546,208
Previous 67,613 707.84%
Holding current value
$10.6 Million
Previous $1.93 Million 325.28%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $5.6 Million - $13.6 Million
478,595 Added 707.84%
546,208 $8.23 Million
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $150,909 - $186,476
5,918 Added 9.59%
67,613 $1.93 Million
Q1 2024

May 15, 2024

SELL
$27.7 - $35.48 $2.25 Million - $2.88 Million
-81,079 Reduced 56.79%
61,695 $1.8 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $893,642 - $1.16 Million
33,953 Added 31.2%
142,774 $4.82 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $2.09 Million - $2.73 Million
68,061 Added 166.98%
108,821 $3.34 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $422,459 - $555,560
11,696 Added 40.24%
40,760 $1.63 Million
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $1.03 Million - $1.26 Million
29,064 New
29,064 $1.19 Million
Q2 2021

Aug 16, 2021

SELL
$59.18 - $69.99 $465,569 - $550,611
-7,867 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $467,184 - $620,865
-7,877 Reduced 50.03%
7,867 $551,000
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $150,148 - $197,123
-2,975 Reduced 15.89%
15,744 $942,000
Q3 2020

Nov 16, 2020

SELL
$51.97 - $63.0 $1.62 Million - $1.97 Million
-31,197 Reduced 62.5%
18,719 $1.13 Million
Q2 2020

Aug 17, 2020

SELL
$30.8 - $52.47 $101,486 - $172,888
-3,295 Reduced 6.19%
49,916 $2.62 Million
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $672,654 - $1.2 Million
23,685 Added 80.22%
53,211 $1.78 Million
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $3.31 Million - $4.27 Million
-91,263 Reduced 75.56%
29,526 $1.34 Million
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $593,810 - $749,173
-16,652 Reduced 12.12%
120,789 $4.6 Million
Q2 2019

Aug 14, 2019

SELL
$36.57 - $47.97 $503,605 - $660,594
-13,771 Reduced 9.11%
137,441 $5.98 Million
Q1 2019

May 14, 2019

BUY
$36.47 - $42.17 $2.69 Million - $3.11 Million
73,862 Added 95.49%
151,212 $5.76 Million
Q4 2018

Feb 14, 2019

BUY
$41.31 - $52.16 $2.99 Million - $3.77 Million
72,259 Added 1419.35%
77,350 $3.33 Million
Q3 2018

Nov 15, 2018

SELL
$32.85 - $52.0 $661,697 - $1.05 Million
-20,143 Reduced 79.82%
5,091 $250,000
Q2 2018

Aug 14, 2018

SELL
$27.5 - $39.8 $1.78 Million - $2.57 Million
-64,594 Reduced 71.91%
25,234 $809,000
Q1 2018

May 15, 2018

BUY
$29.98 - $46.35 $2.69 Million - $4.16 Million
89,828 New
89,828 $2.8 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.